中策集團(00235.HK):467.2萬美元出售面值為500萬美元的債券
格隆匯4月3日丨中策集團(00235.HK)宣佈,於2020年4月3日,公司間接全資附屬佳致於二級市場出售面值為500萬美元的債券,代價為約467.2萬美元。所得款項淨額約466.2萬美元將用作集團的一般營運資金。
監於近期市況波動,董事認為,儘管出售事項產生虧損,經計及集團於過往年度及截至出售事項日期所賺取的利息收入,而出售事項可提供即時流動資金以提升集團的現金狀況,從而使其能夠更佳構建其資產組合,以減低集團於金融市場波動中所承擔之風險,董事認為出售事項符合公司及股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.